Leeford Healthcare is targeting the fast-growing health and personal care segment with its science-based skincare line of products with it’s Alite brand of skincare, as it looks to cater to a growing need in India for affordable, ingredient-based acne care solutions. India’s skincare market is on the rise and the anti-acne category is a key driver of it. Estimates for India’s anti-acne market size of around $350 million in 2024 are based on increasing awareness, acne incidence for younger people, and science-based products.
Leeford’s offerings in skincare is based on a key market observation: while the category has grown rapidly, consumers’ retention and long-term usage are still key, often driven by product experience and ease of use. Amit Gupta, founder and managing director, Leeford Healthcare, “Our experience with 75+ therapeutic segments has shown that outcomes are closely linked to consistency. In skincare, we saw an opportunity to bring a similar approach—creating solutions that consumers can use comfortably over time, rather than short-term fixes.”
Ingredient-Led Differentiation Driving Trust
A trend in the skincare industry is that ingredients are being recognized and consumers are looking at formulation transparency and performance. Alite’s formulations are composed of Niacinamide PC, which is known for skin repair and tolerance, DSBC (Silanediol Salicylate), which is a new derivative to treat acne “& repair acneic skin” with hydration. These ingredients represent the transition from one to multi-purpose to next-generation formulations that can also improve skin compatibility, which is still underpenetrated in the mid-priced range.
Building a scalable consumer healthcare play. Skincare is part of Leeford’s larger strategy to build a diversified consumer healthcare portfolio. With a presence across 75+ therapeutic segments & distribution network of over 1 million retail touchpoints, the company is well-positioned to scale consumer brands, particularly in tier 2 and tier 3 markets, where demand for affordable and quality skincare is growing rapidly. According to industry data, over 60% of skincare consumption growth is now coming from non-metro markets, so distribution strength is a key competitive advantage.
Accessibility and Market Expansion
Leeford is targeting mid-priced, high-efficacy positioning for a segment that spans premium skincare brands and low-cost alternatives. This strategy aligns with a bigger trend in the market towards democratizing access to science-driven skincare to more people in general for the wider community and to make it available to consumers in all types of demographics.
Growth Outlook
The company is expanding Alite’s presence in general trade (pharmacies and retail outlets), modern trade, E-commerce and quick commerce platforms. India’s online beauty and personal care market will also grow rapidly, with 20-25% CAGR (expected) and its brand will be able to grow. Leeford hopes to make Alite a key growth driver in its consumer healthcare portfolio and scale distribution to build brand awareness and penetration in the market.
Bridging Pharma and Consumer Retail
Leeford’s focus in skincare is part of a larger trend of pharmaceutical competency and retail in which credibility and efficacy, access, and accessibility are becoming critical differences. A company with scale, a diverse portfolio and strong distribution infrastructure is positioning itself to tap into the marketplace in healthcare, beauty and retail.
